Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene Lotion 0.1% in Acne Vulgaris
NCT00598832Phase 3Completed
- Sponsor
- Galderma
- Start
- Nov 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in acne vulgaris comparing Adapalene lotion 0.1% with Vehicle (2 arms). Primary endpoints: Success Rate on Investigator's Global Assessment (IGA) at 12 weeks, Absolute Change in Total Lesion Count at 12 weeks and 2 more. Started Nov 2007; status: completed.
02
Drugs
adapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00598832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598832.